Ra Pharma files $100M round as Soliris rival clears phase 2 trial

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 11, 2018 at 11:52 AM.

  1. #1 cafead, Dec 11, 2018 at 11:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,057
    Likes Received:
    3
    via Armed with a phase 2 win for its lead drug zilucoplan in rare disease myasthenia gravis, Ra Pharma has pressed the button on a public funding round that it hopes could raise up to $115 million.

    article source
     
    Quote

Reply to Thread